Diasol, Inc. is recalling approximately 278,600 units of Diasol Liquid Concentrate for Bicarbonate Dialysis because the manufacturer cannot assure the safety or effectiveness of the product. These acid concentrates are used in hospitals and clinics to perform dialysis treatments for patients with kidney failure. The recall was voluntarily initiated by the firm after determining that the quality of the concentrate could not be guaranteed.
If the safety and efficacy of these dialysis concentrates are compromised, patients may receive treatment with incorrect electrolyte levels or contaminated fluids. This could lead to serious health complications, such as electrolyte imbalances or infections during the dialysis process.
Quantity: 186,000 containers; Recall #: Z-0987-2026
Quantity: 7,200 gallons; Recall #: Z-0988-2026
Quantity: 4,400 gallons; Recall #: Z-0989-2026
Quantity: 4,400 gallons; Recall #: Z-0990-2026
Quantity: 74,400 gallons; Recall #: Z-0991-2026
Quantity: 2,200 gallons; Recall #: Z-0992-2026
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.